✦ LIBER ✦

Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients

✍ Scribed by S. Khan; M. Abuzakouk; P. C. Doré; W. A. C. Sewell

Book ID: 107526502
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 233 KB
Volume: 180
Category: Article
ISSN: 1863-4362
DOI: 10.1007/s11845-010-0654-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute thromboembolic events associated w

Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients

✍ Brown, H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Complement consumption associated with e

Complement consumption associated with eczematous cutaneous reaction during infusions of high doses of intravenous immunoglobulin

✍ E. Sarmiento; D. Micheloud; J. Carbone 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Adverse reactions of prophylactic intrav

Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency

✍ Aghamohammadi, Asghar; Farhoudi, Abolhasan; Nikzad, Mohsen; Moin, Mostafa; Pourp 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Bloodstream Infections Associated With a

Bloodstream Infections Associated With a Needleless Intravenous Infusion System in Patients Receiving Home Infusion Therapy

✍ Danzig, Lisa E. 📂 Article 📅 1995 🏛 American Medical Association 🌐 English ⚖ 551 KB

Safety and tolerability of a novel chrom

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura

✍ James B. Bussel; Kim Hanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d

Lack of CD4+CD25+FOXP3+regulatory T cell

Lack of CD4+CD25+FOXP3+regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease

✍ Yu Hirabayashi, Yoshiyuki Takahashi, Yinyan Xu… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 151 KB